Pocket Guide: Biologics in Upper and Lower Airway Diseases 2026 by EUFOREA

A Practical Guide to Biologic Therapies in Airway Diseases

Biologic therapies have significantly transformed the treatment of chronic inflammatory airway diseases over the past decade. By targeting key inflammatory pathways, these treatments offer new opportunities to improve disease control in patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP), asthma, and eosinophilic chronic obstructive pulmonary disease (COPD).

As biologics become increasingly integrated into routine clinical practice, the EUFOREA Pocket Guide: Biologics in Upper and Lower Airway Diseases 2026 provides a practical resource for healthcare professionals navigating this evolving therapeutic landscape.

Drawing on the growing body of clinical and real-world evidence, the publication highlights the effectiveness of biologics beyond controlled clinical trials and explores their potential to achieve new treatment goals, including clinical and complete remission.

This updated pocket guide aims to support healthcare professionals in understanding the role of biologic therapies across upper and lower airway diseases and in applying current evidence to clinical practice.